Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds

Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial

Crafting a better T cell for immunotherapy

Novel treatment makes pancreatic cancer susceptible to immunotherapy, mouse study shows – Washington University School of Medicine in St. Louis

Revealing splenectomy-driven microRNA hsa-7b-5p's role in pancreatic cancer progression - ScienceDirect

The dark side of immunotherapy: pancreatic cancer

Frontiers Translational Learnings in the Development of Chemo- Immunotherapy Combination to Bypass the Cold Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma

When do we say cure for cancer?

Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds

Frontiers Clinical cancer immunotherapy: Current progress and prospects